← FDA Drug Approvals (Drugs@FDA)

GIVLAARI

NDA · New Drug Application · Sponsor: ALNYLAM PHARMS INC · Approved 2019-11-20

Drug application

FDA Application #

NDA212194

Application type

New Drug Application

Brand name

GIVLAARI

Generic name

GIVOSIRAN SODIUM

Active ingredients

GIVOSIRAN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ALNYLAM PHARMS INC

Manufacturer

Alnylam Pharmaceuticals, Inc.

First approval

2019-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown